Resources

James Gilligan
Ph.D, MSIB, a specialist in due diligence and an esteemed drug development scientist and entrepreneur. He has more than 35 years of experience in industry, including international ventures. Jim is a co-author on several of the manufacturing and formulation patents as well as journal articles on novel therapeutic peptides and their clinical utility. He has also been the co-founder of different companies such as Unigene Labs and Tarsa Therapeutics.
Recent Posts

The Clinical Path for Innovation Meeting: Overview and Origins

James Gilligan

Providing Critical Guidance and Connections for a Private Equity Firm Considering a Large Investment

James Gilligan

Kudos to These Companies Pouring Their Resources Into Fighting COVID-19

James Gilligan

Do Biotechs Need Due Diligence Partners? Yes! Here's Why

James Gilligan

The Growing Impact of Artificial Intelligence on Clinical Trials

James Gilligan

Trends in Oncology Clinical Trials

James Gilligan
CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.